4//SEC Filing
Schwab Gisela 4
Accession 0000939767-21-000073
CIK 0000939767other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 7:47 PM ET
Size
8.1 KB
Accession
0000939767-21-000073
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Schwab Gisela
EVP & Chief Medical Officer
Transactions
- Exercise/Conversion
Option (right to buy)
2021-07-21−35,000→ 40,000 totalExercise: $4.20From: 2017-02-11Exp: 2023-02-10→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2021-07-21$4.20/sh+35,000$147,000→ 649,078 total
Holdings
- 14,880(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F2]Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of July 20, 2021.
- [F3]The option, representing the right to purchase a total of 75,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 11, 2020.
Documents
Issuer
EXELIXIS, INC.
CIK 0000939767
Entity typeother
Related Parties
1- filerCIK 0001213140
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 7:47 PM ET
- Size
- 8.1 KB